GB · biotech · biotechnology · cancer therapies
2 rounds we have observed, with the investors named in each. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Growth · May 2026 · $220M
Venrock Healthcare Capital Partners lead, Fidelity Management & Research Company, RA Capital Management, Sofinnova Partners, Forbion, HBM Healthcare, Pfizer
Reported by Ventureburn
Series C · May 2025 · $120M
RA Capital Management lead, Forbion, Avego Bioscience Capital, BrightEdge
Reported by TechStartups
Missing a round, or an investor who was in one? Tell us.